FDA Drug recall D-1145-2017
Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247)
- FDA Drug
- Class I
- terminated
- Published 2017-09-20
On 2017-09-20 the FDA classified a Class I recall of Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247) by Chiavna Saffron, citing marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1145-2017 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2017-07-21 |
| Published | 2017-09-20 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Chiavna Saffron |
| Distribution | US |
Product
Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247); and b) 6 count bottles (UPC# 601577513209), Distributed by SX Power CO., Brooklyn, NY
Reason
Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil
Identifiers
| upc | 6015577513247 |
|---|---|
| upc | 601577513209 |
| code_info | a) RO846356 Exp. 8/28/2020; b) RO246852 Exp. 8/28/2020 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1145-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.